Latest News about RNA
Recent news which mentions RNA
Veritex Holdings, Sequans Communications, Canaan And Other Big Stocks Moving Higher On Monday
July 14, 2025
From Benzinga
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
June 09, 2025
From Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
March 17, 2025
From Benzinga
Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
March 12, 2025
From Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
March 12, 2025
From Benzinga
From Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 20, 2024
From Benzinga
What 8 Analyst Ratings Have To Say About Avidity Biosciences
December 20, 2024
Tickers
RNA
From Benzinga
Assessing Avidity Biosciences: Insights From 10 Financial Analysts
November 13, 2024
Tickers
RNA
From Benzinga
Evaluating Avidity Biosciences: Insights From 10 Financial Analysts
October 21, 2024
Tickers
RNA
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
From Benzinga
Why Avidity Biosciences Zoomed to a 12% Gain This Week
October 04, 2024
From Motley Fool
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
September 24, 2024
From Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
From Benzinga
Tickers
RNA
From InvestorPlace
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
From Benzinga
From InvestorPlace
From Motley Fool